- We will send in 10–14 business days.
/images/books/11288019/9781588294852.jpg)
- Publisher: Humana Press
- Year: 2005
- Pages: 306
- ISBN-10: 1588294854
- ISBN-13: 9781588294852
- Format: 17.7 x 23.7 x 2.7 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Myeloid Leukemia (e-book) (used book) | bookbook.eu
Reviews
Description
A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.19:54:58
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Humana Press
- Year: 2005
- Pages: 306
- ISBN-10: 1588294854
- ISBN-13: 9781588294852
- Format: 17.7 x 23.7 x 2.7 cm, hardcover
- Language: English English
A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered.
Reviews